BSE Live
Nov 17, 10:02Prev. Close
128.90
Open Price
127.20
Bid Price (Qty.)
127.35 (13)
Offer Price (Qty.)
129.50 (3)
NSE Live
Nov 17, 10:02Prev. Close
130.46
Open Price
128.00
Bid Price (Qty.)
128.35 (13)
Offer Price (Qty.)
128.55 (3)
| Cash Flow of Indo US Bio-Tech (in Rs. Cr.) | Mar 22 | Mar 21 | Mar 20 | |
| 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 5.31 | 3.93 | 2.86 | |
| Net CashFlow From Operating Activities | 2.70 | 0.16 | -0.84 | |
| Net Cash Used In Investing Activities | -5.44 | -1.78 | -0.57 | |
| Net Cash Used From Financing Activities | 2.65 | 1.55 | 1.53 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.09 | -0.07 | 0.12 | |
| Cash And Cash Equivalents Begin of Year | 0.13 | 0.20 | 0.08 | |
| Cash And Cash Equivalents End Of Year | 0.05 | 0.13 | 0.20 |
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
17.02.2025
Indo US Bio-Tec Standalone December 2024 Net Sales at Rs 23.56 crore, up 6.56% Y-o-Y
13.08.2024
Indo US Bio-Tec Standalone June 2024 Net Sales at Rs 24.72 crore, up 29.12% Y-o-Y
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
17.02.2025
Indo US Bio-Tec Standalone December 2024 Net Sales at Rs 23.56 crore, up 6.56% Y-o-Y
13.08.2024
Indo US Bio-Tec Standalone June 2024 Net Sales at Rs 24.72 crore, up 29.12% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017